Literature DB >> 31186732

CRKII overexpression promotes the in vitro proliferation, migration and invasion potential of murine hepatocarcinoma Hca-P cells.

Zanmei Zhou1, Xiuyan Sun2, Chunmei Guo2, Ming-Zhong Sun3, Shuqing Liu1.   

Abstract

Lymphatic metastasis is a major mechanism of tumor metastasis. The present study aimed to investigate the association of CRKII, a member of the CRK family, with the in vitro malignant behaviors of a murine hepatocarcinoma Hca-P cell line, with a lymph node metastatic rate of ~25%. Total mRNA was extracted from Hca-P cells, and then the murine CRKII gene was amplified by polymerase chain reaction and cloned into the pEASY-blunt cloning vector. Subsequently, the recombinant pcDNA3.1/V5-HisB-CRKII plasmid was constructed and transfected into Hca-P cells. Western blotting indicated that the CRKII expression level in pcDNA3.1/V5-HisB-CRKII-Hca-P cells was increased by ~185%, compared with pcDNA3.1/V5-HisB-Hca-P cells. The stable overexpression of CRKII enhanced the in vitro proliferation ability, as measured with a Cell Counting Kit-8 assay, and the colony forming capacity was measured with a soft agar colony forming assay for Hca-P cells. The in vitro migration and invasion capacities of Hca-P cells were increased by ~179 and 156% in Hca-P cells, respectively, following the stable upregulation of CRKII. Collectively, the recombinant pcDNA3.1/V5-HisB-CRKII-Hca-P plasmid was constructed successfully. Additionally, the CRKII expression level was positively associated with the in vitro proliferation, migration and invasion malignant properties of Hca-P cells.

Entities:  

Keywords:  CRKII; Hca-P; hepatocarcinoma; invasion; migration; proliferation

Year:  2019        PMID: 31186732      PMCID: PMC6507350          DOI: 10.3892/ol.2019.10194

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

Review 1.  GEFs and GAPs: critical elements in the control of small G proteins.

Authors:  Johannes L Bos; Holger Rehmann; Alfred Wittinghofer
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582

2.  Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis.

Authors:  Ming-Zhong Sun; Shuqing Liu; Jianwu Tang; Zhiqiang Wang; Xiaolin Gong; Chengrong Sun; Frederic Greenaway
Journal:  Proteomics       Date:  2009-06       Impact factor: 3.984

3.  CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells.

Authors:  Sonia P Rodrigues; Kelly E Fathers; Gabriel Chan; Dongmei Zuo; Fawaz Halwani; Sarkis Meterissian; Morag Park
Journal:  Mol Cancer Res       Date:  2005-04       Impact factor: 5.852

4.  Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice.

Authors:  L Hou; Y Li; Y H Jia; B Wang; Y Xin; M Y Ling; S Lü
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 5.  The lymph node as a bridgehead in the metastatic dissemination of tumors.

Authors:  J P Sleeman
Journal:  Recent Results Cancer Res       Date:  2000

6.  Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.

Authors:  Charles T Miller; Guoan Chen; Tarek G Gharib; Hong Wang; Dafydd G Thomas; David E Misek; Thomas J Giordano; John Yee; Mark B Orringer; Samir M Hanash; David G Beer
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

Review 7.  Crk family adaptors-signalling complex formation and biological roles.

Authors:  S M Feller
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

8.  Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.

Authors:  Lei Wang; Kouichi Tabu; Taichi Kimura; Masumi Tsuda; Hua Linghu; Mishie Tanino; Sadao Kaneko; Hiroshi Nishihara; Shinya Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

Review 9.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

10.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Authors:  Raymond B Birge; Charalampos Kalodimos; Fuyuhiko Inagaki; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2009-05-10       Impact factor: 5.712

View more
  1 in total

Review 1.  Crk and CrkL as Therapeutic Targets for Cancer Treatment.

Authors:  Taeju Park
Journal:  Cells       Date:  2021-03-27       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.